[1] Siegel R, Naishadham D, Jemal A.Cancer statistics for Hispanics/Latinos, 2012[J]. CA Cancer J Clin, 2012, 62(5): 283-298. [2] Sano D, Myers JN.Metastasis of squamous cell carcinoma of the oral tongue[J]. Cancer Metastasis Rev, 2007, 26(3-4): 645-662. [3] Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more[J]. Nat Rev Cancer, 2016, 16(7): 431-446. [4] Huang H, Zhang H, Onuma AE, et al.Neutrophil elastase and neutrophil extracellular traps in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1263: 13-23. [5] Ferland DJ, Watts SW.Chemerin: a comprehensive review elucidating the need for cardiovascular research[J]. Pharmacol Res, 2015, 99: 351-361. [6] Treeck O, Buechler C, Ortmann O.Chemerin and cancer[J]. Int J Mol Sci, 2019, 20(15): 3750-3765. [7] Weigert J, Obermeier F, Neumeier M, et al.Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease[J]. Inflamm Bowel Dis, 2010, 16(4): 630-637. [8] Sotiropoulos GP, Dalamaga M, Antonakos G, et al.Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer[J]. Lung Cancer, 2018, 125: 291-299. [9] Zabel BA, Allen SJ, Kulig P, et al.Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades[J]. J Biol Chem, 2005, 280(41): 34661-34666. [10] Mariani F, Roncucci L.Chemerin/chemR23 axis in inflammation onset and resolution[J]. Inflamm Res, 2015, 64(2): 85-95. [11] Wang N, Wang QJ, Feng YY, et al.Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue[J]. Clin Oral Investig, 2014, 18(3): 997-1004. [12] Wang N, Feng Y, Wang Q, et al.Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells[J]. PLoS One, 2014, 9(2): e89991. [13] Zhang W, Gu J, Chen J, et al.Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition[J]. Oncol Rep, 2017, 38(5): 2959-2966. [14] de Souza LF, Pearson AG, Pace PE, et al. Peroxiredoxin expression and redox status in neutrophils and HL-60 cells[J]. Free Radic Biol Med, 2019, 135: 227-234. [15] Wang N, Wang Q, Chi J, et al.Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma[J]. Cancer Sci, 2019, 110(2): 519-529. [16] Wculek SK, Malanchi I.Neutrophils support lung colonization of metastasis-initiating breast cancer cells[J]. Nature, 2015, 528(7582): 413-417. [17] Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their Role in tumorigenesis, metastasis, prognosis and therapy [J]. Front Oncol, 2019, 9: 1146.e1-1146.e16. [18] Mollaoglu G, Jones A, Wait SJ, et al. The Lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment [J]. Immunity, 2018, 49(4): 764-779.e9. [19] Sell H, Laurencikiene J, Taube A, et al.Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells[J]. Diabetes, 2009, 58(12): 2731-2740. [20] Kaur J, Adya R, Tan BK, et al.Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis[J]. Biochem Biophys Res Commun, 2010, 391(4): 1762-1768. [21] Vermi W, Riboldi E, Wittamer V, et al.Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin[J]. J Exp Med, 2005, 201(4): 509-515. [22] Coffelt SB, Kersten K, Doornebal CW, et al.IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis[J]. Nature, 2015, 522(7556): 345-348. [23] Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al.Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice[J]. Hepatology, 2017, 65(6): 1920-1935. [24] Lazennec G, Richmond A.Chemokines and chemokine receptors: new insights into cancer-related inflammation[J]. Trends Mol Med, 2010, 16(3): 133-144. [25] Mantovani A, Allavena P, Sica A, et al.Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444. [26] Del Prete A, Sozio F, Schioppa T, et al.The atypical receptor CCRL2 is essential for lung cancer immune surveillance[J]. Cancer Immunol Res, 2019, 7(11): 1775-1788. |